Azithromycin

Generic Name: Azithromycin

Brand Names: Azasite, Zithromax, Zmax

Drug Type: Small Molecule

Chemical Formula: C_₃₈H_₇₂N_₂O_₁₂

CAS Number: 83905-01-5

Unique Ingredient Identifier: J2KLZ20U1M

Background: Azithromycin is a broad-spectrum macrolide antibiotic with a long half-life and a high degree of tissue penetration . It was initially approved by the FDA in 1991 .
...

Indication: Azithromycin should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria in order to prevent the development antimicrobial resistance and maintain the efficacy of azithromycin .
...

Associated Conditions: Acute Bacterial Sinusitis (ABS), Acute Otitis Media (AOM), Acute bacterial exacerbation of COPD caused by Haemophilus Influenza Infections, Moraxella Catarrhalis Infection, Streptococcus Pneumoniae Infections, Bacterial Conjunctivitis, Bacterial Sinusitis, Cervicitis, Chancroid, Community Acquired Pneumonia (CAP), Genital Ulcer Disease (GUD), Pelvic Inflammatory Disease (PID), Pharyngitis, Streptococcal Pharyngitis, Tonsillitis bacterial, Tonsillitis streptococcal, Traveler's Diarrhea, Uncomplicated Skin and Skin Structure Infections, Urethritis

Associated Therapies: -

Clinical Trials

International ALLIANCE Study of Therapies to Prevent Progression of COVID-19

Phase 2

Conditions: COVID19

Interventions: Dietary Supplement: Vitamin C
Drug: Hydroxychloroquine
Drug: Azithromycin
Dietary Supplement: Zinc Citrate
Dietary Supplement: Vitamin D3
Dietary Supplement: Vitamin B12

First Posted Date: 2020-05-20

Last Posted Date: 2020-09-11

Lead Sponsor: National Institute of Integrative Medicine, Australia

Target Recruit Count: 200

Registration Number: NCT04395768

Locations: 🇦🇺
National Institute of Integrative Medicine, Melbourne, Victoria, Australia

Ultra Low Doses of Therapy With Radiation Applicated to COVID-19

Not Applicable

Suspended

Conditions: Pneumonia, Viral
Cytokine Storm

Interventions: Radiation: Ultra-Low-dose radiotherapy
Device: ventilatory support with oxygen therapy
Drug: Lopinavir/ritonavir
Drug: Hydroxychloroquine
Drug: Azithromycin
Drug: Piperacillin/tazobactam
Drug: Low molecular weight heparin
Drug: Corticosteroid injection
Drug: Tocilizumab

First Posted Date: 2020-05-19

Last Posted Date: 2022-03-29

Lead Sponsor: Fundacion GenesisCare

Target Recruit Count: 15

Registration Number: NCT04394182

Locations: 🇪🇸
Hospital La Milagrosa, GenesisCare, Madrid, Spain
🇪🇸
Hospital Vithas Valencia Consuelo, Valencia, Spain

Randomised Evaluation of COVID-19 Therapy

First Posted Date: 2020-05-11

Last Posted Date: 2024-01-05

Lead Sponsor: University of Oxford

Target Recruit Count: 70000

Registration Number: NCT04381936

Locations: 🇻🇳
Oxford University Clinical Research Unit, Centre for Tropical Medicine, Ho Chi Minh City, Vietnam
🇬🇭
Kumasi Center for Collaborative Research in Tropical Medicine KNUST, Kumasi, Ghana
🇮🇳
Indian Council of Medical Research, Division of Epidemiology and Communicable Diseases, New Delhi, India

and more 4 locations

Low Dose Anti-inflammatory Radiotherapy for the Treatment of Pneumonia by COVID-19

Not Applicable

Conditions: Pneumonia, Viral

Interventions: Radiation: Low-dose radiotherapy
Drug: Hydroxychloroquine Sulfate
Drug: Ritonavir/lopinavir
Drug: Tocilizumab Injection [Actemra]
Drug: Azithromycin
Drug: Corticosteroid
Drug: Low molecular weight heparin
Device: Oxygen supply

First Posted Date: 2020-05-08

Last Posted Date: 2021-07-30

Lead Sponsor: Grupo de Investigación Clínica en Oncología Radioterapia

Target Recruit Count: 106

Registration Number: NCT04380818

Locations: 🇪🇸
Hospital Sant Joan de Reus, Reus, Tarragona, Spain
🇪🇸
Hospital Del Mar, Barcelona, Spain
🇪🇸
Hospital Universitario Madrid Sanchinarro, Madrid, Spain